2/n The update is here: https://www.medrxiv.org/content/10.1101/2020.05.13.20101253v2.full.pdf …
The main question I had was that it looks like they have adjusted for specificity and sensitivity in their final figures - is that right?
-
-
Depends which "final figures" you mean. There seems to be no final report yet, I am using official presentation slides. For the estimate of total prevalence, they report with sens/spec included (95% CI, top left are random samples from population, right are convenience samples)pic.twitter.com/OWmcN7j9yF
-
For the estimate of seropositive w/o symptoms (includes both a- and some pre-symptomatic) the slides are not clear, but since adjustments are explicit on the slide before, I would guess sens/spec is not accounted for. The reported 95% CI for positive w/o symptoms is 27-38%
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.